Key points are not available for this paper at this time.
Figure S3: Lurbinectedin treatment induces regulators of the DNA damage response pathway.
Chakraborty et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: